Evidence map›Paper›PMID 35581224›Full record

ArticleScientific reports2022

Arnaud Briat, Claire Jacques, Mélodie Malige, Laure Sudre, Geoffroy Nourissat, Philippe Auzeloux, Hans Guehring, Florent Cachin, Francis Berenbaum, Elisabeth Miot-Noirault

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Assessment ofFrontiers in medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Arnaud BriatClermont Auvergne University, INSERM U 1240 Molecular Imaging and Theranostic Strategies, F-63000, Clermont-Ferrand, France. arnaud.briat@uca.fr.
Claire JacquesSorbonne University, INSERM U 938 CRSA, Paris, France.
Mélodie MaligeClermont Auvergne University, INSERM U 1240 Molecular Imaging and Theranostic Strategies, F-63000, Clermont-Ferrand, France.
Laure SudreSorbonne University, INSERM U 938 CRSA, Paris, France.
Geoffroy NourissatSorbonne University, INSERM U 938 CRSA, Clinique des Maussins, Groupe Ramsay Générale de Santé, Paris, France.
Philippe AuzelouxClermont Auvergne University, INSERM U 1240 Molecular Imaging and Theranostic Strategies, F-63000, Clermont-Ferrand, France.
Hans GuehringGlobal Clinical Development, Merck KGaA, Darmstadt, Germany.
Florent CachinClermont Auvergne University, INSERM U 1240 Molecular Imaging and Theranostic Strategies, F-63000, Clermont-Ferrand, France.
Francis BerenbaumSorbonne University, INSERM U 938 CRSA, AP-HP Saint-Antoine Hospital, Paris, France.
Elisabeth Miot-NoiraultClermont Auvergne University, INSERM U 1240 Molecular Imaging and Theranostic Strategies, F-63000, Clermont-Ferrand, France.
Inserm · FRMerck (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the emergence of disease modifying osteoarthritis drugs (DMOAD), imaging methods to quantitatively demonstrate their efficacy and to monitor osteoarthritis progression at the functional level are urgently needed. Our group showed that articular cartilage can be quantitatively assessed in nuclear medicine imaging by our radiotracer

Indexed as

Cartilage, ArticularOsteoarthritisAnimalsDisease Models, AnimalFibroblast Growth FactorsHeterocyclic Compounds, 1-RingIndicators and ReagentsMiceProteoglycansQuaternary Ammonium Compoundsfibroblast growth factor 18Fibroblast Growth FactorsHeterocyclic Compounds, 1-RingIndicators and ReagentsN-(triethylammonium)-3-propyl(15)ane-N5ProteoglycansQuaternary Ammonium Compounds

Identifiers

PMID35581224
PMCPMC9113995
OpenAlexW4280545707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.